Perceptyne: Financial Breakdown
Decoding financial health metrics of Perceptyne
Total Revenue₹2.1 Cr
Total Expenses₹2.8 Cr1347%Prev. FY
Profit After Tax₹-68.0 Lakh-258%Prev. FY
Total Assets₹1.5 Cr97%Prev. FY
Net Profit Margin-0.3%
Note: Above mentioned stats are for FY23-24
FAQs on Financials of Perceptyne
No. In FY24, Perceptyne reported a net loss of ₹68.0 Lakh, so it was not profitable.
Perceptyne's estimated EBITDA for FY24 was ₹-44.0 Lakh, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY24, Perceptyne posted revenue of ₹2.1 Cr and a net loss of ₹68.0 Lakh. Explore the full financials of Perceptyne here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links